Table 3. Subgroup Analysis of Compliant Use from the US Study Population of the Global Orthopedic Registry (GLORY).

	LMWH†(N = 973)	Warfarin†(N = 575)	Odds Ratio*(95% CI)	P Value
Bleeding	66 (6.8)	16 (2.8)	3.98 (2.10, 7.56)	<.001
Bleeding Complications	6 (0.6)	1 (0.2)
Surgical site infection*	20 (2.0)	3 (0.4)	5.07 (1.30, 19.77)	0.02
Superficial infection	17 (1.7)	2 (0.3)	5.63 (1.18, 26.99)	0.03
Deep infection	3 (0.4)	1 (0.1)
Reoperation*	29 (3.0)	6 (0.9)	3.42 (1.26, 9.29)	0.02

LMWH: low molecular weight heparin; CI, confidence interval; VTE: venous thromboembolism.

*LMWH vs. Warfarin.

^†Values are given as the number of patients with the percentage in parentheses.